What Every Foreign Device Manufacturer Must Know Before Entering the US Market
Entering the United States medical device market is one of the most commercially valuable moves a foreign manufacturer can make. It is also one of the most technically demanding. The FDA does not grant leniency based on geography, and many international manufacturers underestimate how significantly US requirements diverge from CE marking, Health Canada approval, or TGA registration.
This checklist is designed for founders, regulatory affairs professionals, and quality leaders who need a clear, actionable map of what FDA actually requires before your device can be legally marketed in the US. Miss any of these steps and you risk import holds, Warning Letters, or complete market exclusion.
Step 1: Determine Your Device Classification
Every device marketed in the US must be classified under 21 CFR Parts 862-892. Classification drives your entire regulatory pathway, so get this right first. Use FDA's Product Classification Database and cross-reference your device's intended use against existing predicate devices.
- Class I: General controls, most exempt from premarket submission (though 510(k) exemption is not automatic -- confirm via the classification regulation).
- Class II: General and special controls, typically requires a 510(k) clearance under 21 CFR Part 807.
- Class III: Highest risk, requires a Premarket Approval (PMA) application under 21 CFR Part 814, supported by valid scientific evidence from clinical trials.
If your device is novel with no clear predicate, evaluate the De Novo pathway under Section 513(f)(2) of the FD&C Act before defaulting to PMA.
Step 2: Establish a US Agent and Registered Importer
Foreign manufacturers cannot simply ship product and sell it. Under 21 CFR Part 807.40, every foreign establishment must designate a US Agent -- an individual or firm physically located in the United States who serves as FDA's point of contact. This is not optional. Your US Agent must be reachable at all times during business hours and must be capable of facilitating FDA inspections and communications.
Additionally, if you are importing devices, you need a US Importer of Record who is responsible for ensuring the product complies with FDA regulations at the point of entry. Confusing the US Agent role with the Importer of Record role is a common and costly mistake.
Step 3: Register Your Establishment and List Your Device
Foreign manufacturers must register their establishment with FDA annually using the FURLS/CDRH system, in accordance with 21 CFR Part 807. Registration fees apply and are adjusted annually by FDA. Device listing must be submitted at the time of registration and updated whenever you add, discontinue, or change a device.
Failure to register is a prohibited act under Section 301(p) of the FD&C Act and can result in devices being refused entry at US ports of customs.
Step 4: Comply with Unique Device Identification (UDI) Requirements
Under 21 CFR Part 830 and the FDA UDI Rule, your device label must carry a UDI that includes a Device Identifier (DI) and a Production Identifier (PI). You must obtain your DI from an FDA-accredited issuing agency (GS1, HIBCC, or ICCBBA) and submit device information to the Global Unique Device Identification Database (GUDID).
UDI compliance timelines are tiered by device class. Class III and Class II devices are already required to comply; many Class I devices reached their compliance dates in 2022. Confirm your specific deadline -- non-compliant labeling will be refused entry.
Step 5: Meet FDA Labeling Requirements
Your current CE-marked or internationally approved labeling almost certainly does not meet 21 CFR Part 801 requirements. FDA labeling rules specify mandatory elements including the name and place of business of the manufacturer, adequate directions for use, and -- for prescription devices -- the Rx-only statement. Claims on labeling must match your cleared or approved intended use precisely. Off-label promotional claims are a leading cause of Warning Letters for foreign manufacturers new to the US market.
Step 6: Implement a 21 CFR Part 820-Compliant Quality System
The FDA Quality System Regulation, now aligned with ISO 13485:2016 through the 2024 Quality Management System Regulation (QMSR) under 21 CFR Part 820, requires a documented and implemented QMS. Having ISO 13485 certification from your home country is a strong foundation, but US-specific requirements -- including complaint handling under 820.198 and MDR reporting under 21 CFR Part 803 -- must be explicitly addressed.
FDA investigators conducting inspections of foreign facilities will look for evidence that your QMS is operational, not just documented. Be prepared with objective evidence.
Step 7: Understand Medical Device Reporting (MDR) Obligations
Under 21 CFR Part 803, manufacturers must report device-related deaths and serious injuries to FDA within 30 days (or 5 days for events requiring immediate remedial action). Foreign manufacturers are subject to the same MDR obligations as domestic ones once their device is on the US market. Establish your MDR procedure before your first sale, not after your first adverse event.
Do Not Navigate This Alone
FDA regulations reward preparation and punish assumptions. Many foreign manufacturers attempt to self-navigate US market entry by mapping their existing technical documentation to FDA requirements -- only to discover material gaps during a pre-submission meeting or, worse, during an FDA inspection.
At ADB Consulting and CRO Inc., Andre Butler and the team bring hands-on FDA regulatory expertise to foreign manufacturers at every stage -- from initial classification strategy through 510(k) submission, establishment registration, and audit readiness. Whether you are a startup founder preparing your first US submission or a VP of Regulatory Affairs managing a complex product portfolio, we build the roadmap that gets your device to market without costly detours.
Book your free discovery call today at adbccro.com and get clarity on your fastest, safest path to FDA clearance.
Related reading: our FDA US Agent designation service covers this in more depth.
Ready to Navigate the FDA Process with Confidence?
Book a free 30-minute discovery call with ADB's regulatory team to discuss your specific device and situation.
Book a Free Pathway Call